Overexpression of USP43 induces the growth and stem cell-like properties of cervical cancer by activating ERK1/2 through ZEB1

Cervical cancer (CC) is the most common type of gynecological malignancy in women, and targeting stem cells and inhibiting tumor stem cell-like properties of CC remains an important field of research as an attempt to improve treatment outcomes. This study focused on Ubiquitin-specific-processing Protease 43 (USP43), a member of the deubiquitinase (DUBs) family known to play a role in tumor progression, and analysis of the The Cancer Genome Atlas (TCGA) data and survival computations revealed that USP43 was highly expressed in CC and correlated with poor prognosis. However, the role of USP43 in CC has been under-reported, and its underlying mechanism remains unclear. To investigate the effect and mechanism of USP43, its expression in CC cells and tissues were examined, and the results showed that it was significantly upregulated. Subsequently, knockdown experiments revealed that reducing USP43 expression suppressed CC cell proliferation, and depleting USP43 inhibited the stem cell-like properties of CC cells and impaired their migration abilities. Further investigations indicated that USP43 promoted Zinc finger E-box binding protein 1 (ZEB1)-induced activation of Extracellular regulatory kinase 1/2 (ERK1/2) signaling in CC. Based on these findings, we propose that USP43 could serve as a promising target for CC.

Cervical cancer (CC); USP43; ZEB1; ERK1/2; Stem cell-like properties

[1] Stevens MJ, Ko F, Martland J, Brown R, Bell L, Atyeo J, et al. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic. Radiation Oncology. 2023; 18: 54.

[2] Lin S, Wang M, Cao QQ, Li Q. Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells. FEBS Open Bio. 2020; 10: 1295–1303.

[3] Ouyang F, Liu J, Xia M, Lin C, Wu X, Ye L, et al. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer. Oncology Reports. 2021; 45: 65.

[4] Wang P, Chen C, Zhang QH, Sun GD, Wang CA, Li W. Retraction of lumbar disc herniation achieved by noninvasive techniques: a case report. World Journal of Clinical Cases. 2021; 9: 8082–8089.

[5] Liu L, Huan L, Zhang Y, Wei W, Chen Z, Xu D, et al. Ubiquitin-specific protease 8 inhibits lipopolysaccharide-triggered pyroptosis of human bronchial epithelial cells by regulating PI3K/AKT and NF-κB pathways. Allergologia et Immunopathologia. 2022; 50: 96–103.

[6] Cui N, Li L, Feng Q, Ma HM, Lei D, Zheng PS. Hexokinase 2 promotes cell growth and tumor formation through the Raf/MEK/ERK signaling pathway in cervical cancer. Frontiers in Oncology. 2020; 10: 581208.

[7] Sharma A, Kaur H, De R, Srinivasan R, Pal A, Bhattacharyya S. Knockdown of E-cadherin induces cancer stem-cell-like phenotype and drug resistance in cervical cancer cells. Biochemistry and Cell Biology. 2021; 99: 587–595.

[8] Lin F, Xie Z, Chang L, Li W, Wang L, Hou Y, et al. USP43 promotes tumorigenesis through regulating cell cycle and EMT in breast cancer. International Journal of Clinical and Experimental Pathology. 2017; 10: 11014–11021.

[9] Ye DX, Wang SS, Huang Y, Wang XJ, Chi P. USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer. Journal of Cancer. 2021; 12: 404–416.

[10] Lavaud M, Mullard M, Tesfaye R, Amiaud J, Legrand M, Danieau G, et al. Overexpression of the ubiquitin specific proteases USP43, USP41, USP27x and USP6 in osteosarcoma cell lines: inhibition of osteosarcoma tumor growth and lung metastasis development by the USP antagonist PR619. Cells. 2021; 10: 2268.

[11] Sun Q, Zhang H, Zong L, Julaiti A, Jing X, Zhang L. Prognostic value and oncogenic effects of ubiquitin-specific protease 43 in lung squamous cell carcinoma. The Tohoku Journal of Experimental Medicine. 2022; 257: 135–145.

[12] Hou S, Zhang X, Yang J. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2. Experimental Cell Research. 2022; 410: 112929.

[13] Luan Y, Jiang L, Luan Y, Xie Y, Yang Y, Ren KD. Mitophagy and traumatic brain injury: regulatory mechanisms and therapeutic potentials. Oxidative Medicine and Cellular Longevity. 2023; 2023: 2023:1649842.

[14] Zhang L, Alimu G, Du Z, Yan T, Li H, Ma R, et al. Functionalized magnetic nanoparticles for NIR-induced photothermal therapy of potential application in cervical cancer. ACS Omega. 2023; 8: 21793–21801.

[15] Rey Valzacchi GM, Odetto D, Saadi JM, Zamora LB, Loza C, Medina M, et al. Conservative treatment of cervical cancer: a single center experience over a two-decade period. Gynecologic Oncology Reports. 2023; 48: 101226.

[16] Zhao Z, Lin Z, Guo X, Al-danakh A, He H, Qin H, et al. Ubiquitin-specific protease 43 impacts pancreatic ductal adenocarcinoma prognosis by altering its proliferation and infiltration of surrounding immune cells. Journal of Immunology Research. 2023; 2023: 4311388.

[17] Lin Z, Huang J, Zhu L, Lin X, Huang Y, Chen C, et al. TRIM9 interacts with ZEB1 to suppress esophageal cancer by promoting ZEB1 protein degradation via the UPP pathway. BioMed Research International. 2023; 2023: 2942402.

[18] Wu C, Hou X, Li S, Luo S. Long noncoding RNA ZEB1-AS1 attenuates ferroptosis of gastric cancer cells through modulating miR-429/BGN axis. Journal of Biochemical and Molecular Toxicology. 2023; 37: e23381.

[19] Han Y, Luo Y, Wang Y, Chen Y, Li M, Jiang Y. Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway. Oncology Letters. 2016; 11: 753–759.

[20] Lang SJ, Schmiech M, Hafner S, Paetz C, Werner K, El Gaafary M, et al. Chrysosplenol D, a flavonol from Artemisia annua, induces ERK1/2-mediated apoptosis in triple negative human breast cancer cells. International Journal of Molecular Sciences. 2020; 21: 4090.

[21] Li B, Xiao Q, Shan L, Song Y. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. Cell Cycle. 2022; 21: 427–438.

[22] Gao Y, Li H, Han Q, Li Y, Wang T, Huang C, et al. Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway. Journal of Cancer. 2020; 11: 3151–3164.